Skip to main content
. 2021 Aug 17;11(8):2421. doi: 10.3390/ani11082421

Table 3.

Effects of experimental diets 1 and lactation phase on fatty acid (FA) composition of milk.

Item 3 (g/100 g FA) Diet (D) 1 Lactation Phase (LP)) SEM p 2
Control DOP40 DOP80 Early Mid Late D LP D × LP
C4:0 3.65 3.48 3.57 3.60a 3.74a 3.34b 0.03 ns *** ns
C6:0 4.85a 4.52b 4.67ab 4.78a 4.84a 4.39b 0.04 ** *** **
C8:0 4.17a 3.87b 4.00b 4.10a 4.15a 3.76b 0.03 *** *** *
C10:0 9.86a,b 9.53b 10.13a 9.69b 10.62a 9.14c 0.08 ** *** ns
C11:0 0.07a 0.06b 0.06b 0.07a 0.07a 0.06b 0.00 *** *** ns
C12:0 5.58a 5.40b 5.39b 5.46a 5.59a 5.29b 0.04 * ** ns
C13:0 0.06 0.06 0.06 0.06a 0.06a 0.05b 0.00 ns *** ns
C14:0 7.30b 7.46a,b 7.54a 7.09b 6.99b 8.22a 0.06 * *** ***
C14:1 0.19 0.19 0.19 0.19 0.19 0.19 0.00 ns ns ns
C15:0 0.52 0.51 0.51 0.52 0.52 0.49 0.01 ns ns ***
C15:1 0.03 0.03 0.03 0.03 0.03 0.03 0.00 ns ns ns
C16:0 24.4b 25.1a 24.4b 24.6b 24.2c 25.3a 0.10 ** *** *
C16:1 1.01 1.01 1.00 1.01 1.01 1.00 0.01 ns ns **
C17:0 0.33 0.35 0.32 0.32 0.32 0.35 0.00 ns ns ns
C17:1 0.09b 0.11a 0.10a,b 0.09b 0.09b 0.12a 0.00 ** *** ***
C18:0 11.4 11.3 10.9 11.5a 10.8b 11.2a,b 0.10 ns ** ***
C18:1 n-9 trans 0.97a 0.91b 0.89b 0.94a 0.96a 0.85b 0.01 *** *** **
C18:1 n-11 trans (VA) 0.68 0.70 0.67 0.67 0.68 0.71 0.01 ns ns **
C18:1 n-9 cis 19.6b 20.0a,b 20.3a 19.9a,b 19.7b 20.3a 0.09 * * *
C18:2 n-6 trans 0.15b 0.19a 0.17a 0.14b 0.15b 0.23a 0.01 ** *** ***
C18:2 n-6 cis 3.20 3.30 3.23 3.31a 3.35a 3.08b 0.03 ns *** ***
γ -C18:3 n-6 0.11a 0.10b 0.09b 0.09b 0.09b 0.12a 0.00 *** *** ***
α -C18:3 n-3 0.21 0.22 0.22 0.21b 0.21b 0.23a 0.00 ns * **
CLA cis-9, trans-11 (RA) 0.69a 0.67a,b 0.65b 0.68a,b 0.69a 0.64b 0.01 * * **
CLA trans-10, cis-12 0.01 0.02 0.02 0.01b 0.01b 0.02a 0.00 ns *** ***
C20:0 0.22a 0.20b 0.20b 0.21a 0.21a 0.19b 0.00 * * ns
C20:1 n-9 0.04 0.04 0.04 0.04 0.04 0.04 0.00 ns ns ns
C20:2 0.06 0.06 0.06 0.06 0.06 0.06 0.00 ns ns ns
C20:3 n-3 0.02 0.03 0.02 0.03 0.03 0.03 0.00 ns ns ns
C20:3 n-6 0.03 0.03 0.03 0.03 0.03 0.03 0.00 ns ns ***
C20:4 n-6 0.20 0.20 0.20 0.19b 0.20b 0.21a 0.00 ns ** ***
C20:5 n-3 0.03 0.03 0.03 0.03 0.03 0.03 0.00 ns ns ns
C21:0 0.02 0.02 0.02 0.02 0.02 0.02 0.00 ns ns ns
C22:0 0.11 0.11 0.10 0.12a 0.12a 0.09b 0.00 ns *** ns
C22:1 n-9 0.02 0.02 0.02 0.02 0.02 0.02 0.00 ns ns ns
C22:2 0.01 0.01 0.01 0.01b 0.01b 0.02a 0.00 ns *** ns
C22:5 n-3 0.05 0.05 0.05 0.05 0.06 0.05 0.00 ns ns ***
C22:6 n-3 0.02 0.02 0.02 0.02 0.02 0.02 0.00 ns ns ns
C23:0 0.02 0.02 0.02 0.02 0.02 0.02 0.00 ns ns ns
C24:0 0.02 0.02 0.02 0.02a 0.02a 0.01b 0.00 ns * ns
C24:1 0.01 0.01 0.01 0.01 0.01 0.01 0.00 ns ns ns
SFA 72.5a 72.0a,b 72.0b 72.2 72.3 72.0 0.09 * ns ***
MUFA 22.6b 23.0a,b 23.2a 23.0a,b 22.7b 23.3a 0.08 * * *
PUFA 4.82 4.94 4.81 4.87a,b 4.94a 4.77b 0.03 ns * ***
SCFA 22.5a 21.4b 22.4a 22.2b 23.3a 20.6c 0.14 *** *** **
MCFA 39.6b 40.3a 39.6b 39.4b 39.1c 41.1a 0.13 ** *** **
LCFA 37.9 38.3 38.0 38.4a 37.6b 38.3a 0.11 ns ** ***
n-3 0.34 0.34 0.34 0.33b 0.35a,b 0.36a 0.00 ns *** ns
n-6 3.69 3.83 3.72 3.77a,b 3.82a 3.67b 0.03 ns * ***
CLA total 0.71a 0.69a,b 0.67b 0.69a,b 0.70a 0.66b 0.01 * * ***
n-6:n-3 10.8 11.2 10.9 11.5a 11.0b 10.4c 0.11 ns *** **
MUFA/SFA 0.31b 0.32a,b 0.33a 0.32 0.31 0.32 0.00 * ns **
PUFA/SFA 0.07 0.07 0.07 0.07 0.07 0.07 0.00 ns ns ***
DI C16:0 0.04 0.04 0.04 0.04 0.04 0.04 0.00 ns ns **
DI C18:0 0.65b 0.66a,b 0.67a 0.65 0.66 0.66 0.00 ** ns ***
CLA index 0.50 0.49 0.49 0.50a 0.50a 0.48b 0.00 ns * ***
AI 2.16 2.16 2.14 2.10b 2.10b 2.27a 0.01 ns *** ns
TI 3.02a 3.02a 2.94b 3.00b 2.92c 3.06a 0.02 * *** ns

For each main effect type, means with different letters (a, b, c) within each row differ significantly (p ≤ 0.05); 1 See Table 1; 2 ns, not significant (p > 0.05); *, p ≤ 0.05; **, p < 0.01; ***, p < 0.001; 3 SCFA, short-chain FAs (C4:0-C10:0); MCFA, medium-chain FAs (C11:0-C17:1); LCFA, long-chain FAs (C18:0-C24:1); DI C16:0, desaturation index of C16:0 [C16:1 FAs/(C16:0 + C16:1 FAs)]; DI C18:0, desaturation index of C18:0 [C18:1 FAs/(C18:0 + C18:1 FAs)]; CLA desaturase index [rumenic acid, RA/(vaccenic acid, VA + RA)]; AI, atherogenic index [(C12:0 + 4 x C14:0 + C16:0)/(MUFA + PUFA)]; TI, thrombogenic index [(C14:0 + C16:0 + C18:0)/(0.5 x MUFA + 0.5 x n-6 PUFA + 3 x n-3 PUFA) + (n-3 PUFA/n-6 PUFA)].